RxSight Light Adjustable Lens and Light Delivery Device
Rxsight, Inc. · Decision date Nov 5, 2026
What did the FDA approve?
FDA lists this as an approval for a supplement to PMA P160055 for RxSight’s Light Adjustable Lens and Light Delivery Device, not a new PMA for the system. The supplied record places it in the ophthalmic device category and identifies the supplement type as a Real-Time Process change tied to design, components, specifications, or material.
The changed item is the Align Assist module: the record says the modification replaces the current template-matching lens identification method with an updated locked machine learning (ML)-based lens identification algorithm. The source does not provide the algorithm’s training data, validation results, performance metrics, or any new clinical indication; it only states the requested change in identification method.
FDA approval order statement
approval for Align Assist module modification proposing replacement of the current template-matching based lens identification methodology with an updated locked machine learning (ML)-based lens identification algorithm
- Regulatory pathway
- PMA supplement
- Supplement type
- Real-Time Process
- Clinical specialty
- Ophthalmic
- Decision date
- Nov 5, 2026
- FDA change category
- Change Design/Components/Specifications/Material
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P160055/S057
- Regulatory pathway
- PMA supplement
- Applicant
- Rxsight, Inc.
- Product code
- PZK
- Decision code
- APPR
- Decision date
- Nov 5, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Light adjustable lens (LAL) and light delivery device (LDD).
- Applicant
- Rxsight, Inc.
- Product code
- PZK
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P160055. Subsequent supplements may change the device or its indications.
FDA decision timeline
P160055 · Original PMA
LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD)
P160055/S057 received
Application receipt date recorded by FDA.
P160055/S056 · Related supplement
RxSight Light Adjustable Lens and Light Delivery Device
P160055/S058 · Related supplement
RxSight Light Adjustable Lens and Light Delivery Device
P160055/S057 · FDA decision
Real-Time Process
Timeline entries are records held by MedtechLedger for P160055. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P160055
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Rxsight, Inc. | PMA approval | Nov 22, 2017 | FDA | |
| Rxsight, Inc. | PMA supplement | Sep 3, 2026 | FDA | |
| Rxsight, Inc. | PMA supplement | Oct 22, 2026 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Rxsight, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 100 Columbia, Aliso Viejo, CA, 92656
Sources and methodology
- Original FDA record: P160055/S057
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

